As the post-pandemic world of work continues to evolve, so do recruiters’ strategies and tools for finding and engaging top talent. In 2023, we are seeing these seven trends:1. Employer branding is becoming an increasingly important factor in the recruitment…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Regulatory Review Trend in Japan Signals Pharmas’ Shift to Cancer Drugs: Jiho Tally
July 30, 2014
-
REGULATORY NIBIO Initiates Support for Applied Research on 15 Promising Drug Seeds with Goal of First Licensing Agreement by FY2015
July 30, 2014
-
REGULATORY MHLW to Review Criteria for Clinical Research Core Hospitals by April
July 29, 2014
-
BUSINESS AbbVie Hopes to Make Humira Major Drug for Biologics-Naïve Patients: President
July 28, 2014
-
ORGANIZATION JPMA President Hints at Adoption of Unified System to Disclose Fees Paid to Doctors Next Year
July 25, 2014
-
BUSINESS Ono, BMS Announce Strategic Alliance for 5 Immuno-Oncology Products
July 25, 2014
-
BUSINESS Astellas Gears Up to Accelerate R&D
July 24, 2014
-
REGULATORY Chain Pharmacies’ Drug Price Settlement Rate in June Triples from 2 Years Ago
July 23, 2014
-
BUSINESS Disclosure of Payments from Drug Makers to Doctors Delayed
July 22, 2014
-
BUSINESS Carna Shooting for 1st Licensing Deal on Kinase Inhibitor in 2014
July 18, 2014
-
BUSINESS Merck Serono Japan Hopes to Boost Erbitux Share by Narrowing Down CRC Patients: President
July 17, 2014
-
BUSINESS Ono President Professes High Hopes for Newly Approved Anticancer Drug Opdivo
July 16, 2014
-
BUSINESS Ex-Astellas Chair Sounds Alarm over Oncology-Focused Businesses, Says Govt Finances Will Be Insufficient
July 15, 2014
-
BUSINESS “Favorable Transactions” for Nesp in Return for Support in Clinical Trial: Independent Panel
July 14, 2014
-
REGULATORY Is Legal Regulation Necessary? Clinical Research at Turning Point 1: TRI Director Fukushima
July 14, 2014
-
BUSINESS Takata Seiyaku Looks to Sales of 30 Billion Plus Yen by 2016
July 11, 2014
-
BUSINESS Novartis Lays Out New Global Guidelines for Investigator-Led Trials
July 10, 2014
-
BUSINESS Bayer Yakuhin Sees Cancer Drugs as New Pillar
July 9, 2014
-
BUSINESS MTPC Aspires to Derive 30% of Sales from Offshore Biz
July 8, 2014
-
BUSINESS Sanofi to Bounce Back with New Portfolios, Shift to “Mabs”: Pres.
July 7, 2014
ページ
Novo Nordisk’s weight-loss medication Wegovy (semaglutide) was approved in Japan in March. While it skipped the May round of reimbursement listing, physicians eagerly await the arrival of what would be the first new obesity drug in three decades. Other companies…
Japan’s health ministry on April 27 presented an outline of a report to be compiled next month by its key…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…